Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L : revenue, balance sheet and financial ratios

SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L is a French company founded 8 years ago, specialized in the sector Gestion de fonds. Based in MONT-SAINT-AIGNAN (76130), this company of category PME shows in 2024 a net income positive of 131 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-11

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L (SIREN 838444362)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C
Net income 130 661 € 92 044 € 883 125 € -2 721 € -7 904 € 75 488 €
EBITDA -7 683 € -39 834 € -2 735 € -3 779 € -4 095 € -4 163 €
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L generates positive net income of 131 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 75 k€ -> 131 k€.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-7 683 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-7 684 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

130 661 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

12.814%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

88.55%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.95

Solvency indicators evolution
SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L

Sector positioning

Debt ratio
12.81 2024
2022
2023
2024
Q1: 0.0
Med: 8.28
Q3: 92.71
Average +26 pts over 3 years

In 2024, the debt ratio of SPFPL FARMALOR SOCIETE DE... (12.81) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
88.55% 2024
2022
2023
2024
Q1: 4.63%
Med: 48.43%
Q3: 87.31%
Excellent

In 2024, the financial autonomy of SPFPL FARMALOR SOCIETE DE... (88.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.95 years 2024
2022
2023
2024
Q1: -0.01 years
Med: 0.0 years
Q3: 3.01 years
Average +16 pts over 3 years

In 2024, the repayment capacity of SPFPL FARMALOR SOCIETE DE... (1.95) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 11395.14. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

11395.136

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-6.156

Liquidity indicators evolution
SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L

Sector positioning

Liquidity ratio
11395.14 2024
2022
2023
2024
Q1: 100.71
Med: 472.45
Q3: 3122.85
Excellent

In 2024, the liquidity ratio of SPFPL FARMALOR SOCIETE DE... (11395.14) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-6.16x 2024
2022
2023
2024
Q1: -71.11x
Med: 0.0x
Q3: 0.0x
Average

In 2024, the interest coverage of SPFPL FARMALOR SOCIETE DE... (-6.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 91 days. Excellent situation: suppliers finance 91 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

91 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L

Positioning of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 62 transactions of similar company sales in 2024, the value of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L is estimated at 965 748 € (range 274 201€ - 1 913 251€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
62 tx
274k€ 965k€ 1913k€
965 748 € Range: 274 201€ - 1 913 251€
NAF 5 année 2024

Valuation method used

Net Income Multiple
130 661 € × 7.4x = 965 749 €
Range: 274 201€ - 1 913 252€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L with other companies in the same sector:

Voir toutes les statistiques du secteur Gestion de fonds

Frequently asked questions about SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L

What is the revenue of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L ?

The revenue of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L profitable?

Yes, SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L generated a net profit of 131 k€ in 2024.

Where is the headquarters of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L ?

The headquarters of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L is located in MONT-SAINT-AIGNAN (76130), in the department Seine-Maritime.

Where to find the tax return of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L ?

The tax return of SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L operate?

SPFPL FARMALOR SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE DE PHARMACIENS D'OFFICINE A RESPONSABILITE L operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.